Overexpression of cytokine CCL5 in CTNNB1-mutant HCC cells led to the recruitment of CD103+ DCs and antigen-specific CD8+ T cells, which may enhance the clinical outcome of ICI therapy (165). Here, CD8A is linked to hepatocellular carcinoma.